JP Morgan Chase
EOLS icon

JP Morgan Chase’s Evolus EOLS Stock Holding History

JP Morgan Chase’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-110,000
Closed -$1.19M – 7480
2024
Q2 		$1.19M Buy
+110,000
New +$1.35M ﹤0.01% 4157
2020
Q2 		– Sell
-16,100
Closed -$67K – 5455
2020
Q1 		$67K Sell
16,100
-62,200
-79% -$527K ﹤0.01% 4639
2019
Q4 		$953K Buy
78,300
+18,100
+30% +$255K ﹤0.01% 3904
2019
Q3 		$940K Buy
60,200
+25,400
+73% +$416K ﹤0.01% 3871
2019
Q2 		$500K Hold
34,800
– – ﹤0.01% 4235
2019
Q1 		$785K Buy
+34,800
New +$752K ﹤0.01% 3951

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

JP Morgan Chase's EOLS Position: Q2 2026 in Review

JP Morgan Chase increased its Evolus (EOLS) stake by 6% in Q2 2026, buying an estimated $11.1K and bringing the position to 33,349 shares worth $238K. The position accounts for ﹤0.01% of the portfolio, ranked #5528.

JP Morgan Chase first reported a position in EOLS in Q1 2018 and has held it in 34 quarters since. The position peaked at $8.76M in Q1 2025. 158 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.

  • JP Morgan Chase held 33,349 shares of Evolus worth $238K as of Q2 2026.
  • JP Morgan Chase bought 1,873 Evolus shares in Q2 2026, an estimated $11.1K.
  • Evolus made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #5528 holding.
  • JP Morgan Chase first reported a position in Evolus in Q1 2018 and has held it in 34 quarters since.
  • JP Morgan Chase's Evolus position peaked at $8.76M in Q1 2025.
  • 158 funds tracked by Wall St. Rank held Evolus as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.